Loeb's Calls For Acorda Therapeutics (ACOR) To Sell

Daniel S. Loeb's Third Point LLC sent a letter to Acorda Therapeutics (Nasdaq: ACOR) stating the Board of Directors should immediately retain an investment bank and pursue a process to sell the Company in its entirety